Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory
Neurol 98:486-498, Turan, T.N.,et al, 2022
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Cerebrovascular Complications of Neurocysticercosis
The Neurologist 18:17-22, Marquez, J.M. and Arauz, A., 2012
Progress in Secondary Stroke Prevention
Ann Neurol 63:418-427, Romano,J.G. &Sacco,R.L., 2008
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008
Stroke and Multi-Infarct Dementia as Presenting Symptoms of Giant Cell Arteritis: Report of 7 Cases and Review of the Literature
Medicine 87:335-344, Solans-Laque,R.,et al, 2008
Association of the Metabolic Syndrome with Intracranial Atherosclerotic Stroke
Neurol 65:296-298,188, Bang,O.Y.,et al, 2005
Improved Cerebrovascular Patency Following Therapy in Patients with Sickle Cell Disease: Initial Results in 4 Patients Who Received HLA-Identical Hematopoietic Stem Cell Allografts
Ann Neurol 49:222-229, Steen,R.G.,et al, 2001
Neurologic Complications of the Reactivation of Varicella-Zoster Virus
NEJM 342:635-645, Gilden,D.H.,et al, 2000
Prevent of a 1st Stroke by Transfusions in Children/Sickle Cell Anemia & Abnorm Results on Transcr Doppler Ultrasonog
NEJM 339:5-11, Adams,R.J.,et al, 1998
The Warfarin-Aspirin Symptomatic Intracranial Disease Study
Neurol 45:1488-1493, Chimowitz,M.I.,et al, 1995